社区药房技术平台提升成人免疫接种率的效果
研究在内布拉斯加州和爱荷华州159家社区药房利用药师为19岁及以上成人接种疫苗,并实施药房技术平台与州免疫登记系统对接。使用平台一年后,流感、带状疱疹和百日咳疫苗接种率分别较前一年增加37%、12%和74%,但肺炎球菌疫苗接种率下降约16%。内布拉斯加州参与药房首次向州免疫登记系统报告接种数。
要点
- 药房技术平台对接州免疫登记可提升成人流感、带状疱疹和百日咳接种率。
- 肺炎球菌疫苗接种率在使用平台一年后下降约16%。
- 社区药房可作为成人免疫接种和社区预防网络的重要场所。
核心结论
- 实施药房技术平台并与州免疫登记系统对接一年后,流感、带状疱疹和百日咳疫苗接种率分别增加37%、12%和74%,但肺炎球菌疫苗接种率下降约16%。
研究设计与样本
- 项目利用内布拉斯加州和爱荷华州159家社区药房的药师,为19岁及以上成人接种疫苗,并实施药房技术平台与两州州免疫登记系统对接。
主要发现
- 与上一年相比,流感、带状疱疹和百日咳疫苗接种率分别增加37%、12%和74%。
- 肺炎球菌疫苗接种率下降约16%。
- 内布拉斯加州参与药房首次向州免疫登记系统报告免疫接种数。
临床怎么用
- 社区药房可借助技术平台对接州免疫登记系统,提升成人免疫接种率并构建社区预防网络。
局限性
- 州免疫登记系统报告对医疗保健提供者目前为自愿,可能影响数据完整性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Over the course of this project, we utilized pharmacists at 159 community pharmacies in Nebraska and Iowa to administer vaccinations to adults 19 years of age or older with the objective of improving immunization rates in both states. We implemented a pharmacy-based technology platform and partnered with public health via the state immunization registries of both states to ensure that immunizations provided at the pharmacy were transmitted to the statewide registry, for which reporting is currently voluntary for health care providers. After using the technology platform for one year, an increase of immunization rates for influenza, herpes zoster, and pertussis vaccination rates by 37%, 12%, and 74%, respectively, was recorded in comparison to the prior year numbers. However, there was about 16% decrease in vaccination rates for pneumococcal vaccine. For the first time, the project's participating pharmacies in Nebraska reported immunization counts to their state's immunization registries. This project leveraged community pharmacies as healthcare destinations to achieve further gains in increasing immunization rates, improving the health of adults, and creating a community-wide network for prevention.
引用
- Wehbi NK, Wani RJ, Klepser DG, et al. Impact of implementing a technology platform in community pharmacies to increase adult immunizations rates. Vaccine. 2018. PMID: 30471954. doi:10.1016/j.vaccine.2018.11.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。